Bártolo, I., Borrego, P., Gomes, P., Gonçalves, F., Caixas, U., Pinto, I. V., & Taveira, N. (2019). In vitro evaluation of novel reverse transcriptase inhibitors TAF (tenofovir alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) against multi-drug resistant primary isolates of HIV-2.
Citação do estilo Chicago (17ª ed.)Bártolo, Inês, Pedro Borrego, Perpétua Gomes, Fátima Gonçalves, Umbelina Caixas, Inês V. Pinto, e Nuno Taveira. In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-drug Resistant Primary Isolates of HIV-2. 2019.
Citação MLA (8ª ed.)Bártolo, Inês, et al. In Vitro Evaluation of Novel Reverse Transcriptase Inhibitors TAF (tenofovir Alafenamide) and OBP-601 (2,3-didehydro-3-deoxy-4-ethynylthymidine) Against Multi-drug Resistant Primary Isolates of HIV-2. 2019.